Zacks Investment Research
20 Jul 2026, 17:46 UTC · 13h ago
3 Reasons Why Growth Investors Shouldn't Overlook Cimpress (CMPR)
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
Zacks Investment Research
20 Jul 2026, 17:46 UTC · 13h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
What the story claims
2 claims · each scored for market impact
Cimpress (CMPR) is projected to achieve earnings per share (EPS) growth of 18.7% this year, significantly exceeding the industry average of 9.2%. — Projected earnings growth that doubles the industry average is a primary catalyst for stock price appreciation in growth-oriented investing.
+0.40Cimpress reports a sales-to-total-assets (S/TA) ratio of 1.81, which is higher than the industry average of 1.64. — Better-than-average asset utilization indicates superior operational efficiency, which supports a positive valuation but is less impactful than EPS growth.
+0.20Which stocks this story touches
The company is identified as a great growth pick with a top Zacks Rank and projected earnings growth that crushes the industry average.
Continue reading
6 related stories
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Zacks Investment Research
13h ago
